These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Diffusion and perfusion imaging in subacute neurotoxicity following high-dose intravenous methotrexate. Eichler AF; Batchelor TT; Henson JW Neuro Oncol; 2007 Jul; 9(3):373-7. PubMed ID: 17522329 [TBL] [Abstract][Full Text] [Related]
5. Nuclear magnetic resonance abnormalities of the cerebral white matter in children with acute lymphoblastic leukemia and malignant lymphoma during and after central nervous system prophylactic treatment with intrathecal methotrexate. Asato R; Akiyama Y; Ito M; Kubota M; Okumura R; Miki Y; Konishi J; Mikawa H Cancer; 1992 Oct; 70(7):1997-2004. PubMed ID: 1525778 [TBL] [Abstract][Full Text] [Related]
6. Methotrexate-induced Subacute Encephalopathy That Showed No Abnormalities on Magnetic Resonance Imaging Soon after Symptom Appearance. Fujisawa H; Mitsui Y; Narukawa K; Shirasugi Y; Komaki S; Hao A; Matsumoto H; Takahashi T Intern Med; 2023 Aug; 62(15):2249-2252. PubMed ID: 36476551 [TBL] [Abstract][Full Text] [Related]
7. Randomized Phase III study of 5-fluorouracil continuous infusion vs. sequential methotrexate and 5-fluorouracil therapy in far advanced gastric cancer with peritoneal metastasis (JCOG0106). Shirao K; Boku N; Yamada Y; Yamaguchi K; Doi T; Goto M; Nasu J; Denda T; Hamamoto Y; Takashima A; Fukuda H; Ohtsu A; Jpn J Clin Oncol; 2013 Oct; 43(10):972-80. PubMed ID: 24014884 [TBL] [Abstract][Full Text] [Related]
8. Pure methotrexate encephalopathy presenting with seizures: CT and MRI features. Lövblad K; Kelkar P; Ozdoba C; Ramelli G; Remonda L; Schroth G Pediatr Radiol; 1998 Feb; 28(2):86-91. PubMed ID: 9472050 [TBL] [Abstract][Full Text] [Related]
9. Magnetization transfer imaging provides no evidence of demyelination in methotrexate-induced encephalopathy. Miese FR; Schuster FR; Pierstorff K; Karenfort M; Laws HJ; Borkhardt A; Saleh A AJNR Am J Neuroradiol; 2011; 32(6):E110-2. PubMed ID: 20651019 [TBL] [Abstract][Full Text] [Related]
10. Acute neurotoxicity in children with B-precursor acute lymphoid leukemia: an association with intermediate-dose intravenous methotrexate and intrathecal triple therapy--a Pediatric Oncology Group study. Mahoney DH; Shuster JJ; Nitschke R; Lauer SJ; Steuber CP; Winick N; Camitta B J Clin Oncol; 1998 May; 16(5):1712-22. PubMed ID: 9586883 [TBL] [Abstract][Full Text] [Related]
11. A Case of Subacute Encephalopathy Developing After Treatment With Clofarabine and Methotrexate That Resolved With Corticosteroids. Tzachanis D; Haider M; Papazisis G Am J Ther; 2016; 23(3):e937-40. PubMed ID: 24987945 [TBL] [Abstract][Full Text] [Related]
13. [Subacute encephalopathy after high-dose methotrexate as prophylaxis for central nervous system relapse in a patient with intravascular large B-cell lymphoma]. Watanabe M; Kaji D; Hashimoto-Maeda M; Yamamoto G; Asano-Mori Y; Uchida N; Taniguchi S; Izutsu K Rinsho Ketsueki; 2015 Mar; 56(3):329-34. PubMed ID: 25876788 [TBL] [Abstract][Full Text] [Related]
14. Transient focal leukoencephalopathy following intraventricular methotrexate and cytarabine. A complication of the Ommaya reservoir: case report and review of the literature. Colamaria V; Caraballo R; Borgna-Pignatti C; Marradi P; Balter R; Mazza C; Procacci C; Dalla Bernardina B Childs Nerv Syst; 1990 Jun; 6(4):231-5. PubMed ID: 2200610 [TBL] [Abstract][Full Text] [Related]
15. [Transient cerebral dysfunction induced by VCR, HD-MTX in a child with acute lymphocytic leukemia]. Sato J; Yuasa Y; Tanaka H; Ninomiya T; Hirose M; Miyao M Rinsho Ketsueki; 1986 Nov; 27(11):2162-7. PubMed ID: 3469437 [No Abstract] [Full Text] [Related]
16. Posterior reversible encephalopathy syndrome associated with methotrexate neurotoxicity: conventional magnetic resonance and diffusion-weighted imaging findings. Dicuonzo F; Salvati A; Palma M; Lefons V; Lasalandra G; De Leonardis F; Santoro N J Child Neurol; 2009 Aug; 24(8):1013-8. PubMed ID: 19307676 [TBL] [Abstract][Full Text] [Related]
17. Sequential moderate-dose methotrexate and 5-fluorouracil in advanced gastric adenocarcinoma. Dickinson R; Presgrave P; Levi J; Milliken S; Woods R Cancer Chemother Pharmacol; 1989; 24(1):67-8. PubMed ID: 2720894 [TBL] [Abstract][Full Text] [Related]
18. [Combination chemotherapy of CPM-MTX-5-FU in non-resectable and recurrent cancer patients]. Saeki T; Jinushi K; Kim R; Toi M; Saeki K; Yoshinaka K; Yanagawa E; Niimoto M; Hattori T Gan To Kagaku Ryoho; 1989 Apr; 16(4 Pt 1):827-31. PubMed ID: 2712579 [TBL] [Abstract][Full Text] [Related]
19. Toxic epidermal necrolysis following combination of methotrexate and trimethoprim-sulfamethoxazole. Yang CH; Yang LJ; Jaing TH; Chan HL Int J Dermatol; 2000 Aug; 39(8):621-3. PubMed ID: 10971734 [TBL] [Abstract][Full Text] [Related]
20. Phase II study of sequential methotrexate and 5-fluorouracil chemotherapy against peritoneally disseminated gastric cancer with malignant ascites: a report from the Gastrointestinal Oncology Study Group of the Japan Clinical Oncology Group, JCOG 9603 Trial. Yamao T; Shimada Y; Shirao K; Ohtsu A; Ikeda N; Hyodo I; Saito H; Iwase H; Tsuji Y; Tamura T; Yamamoto S; Yoshida S Jpn J Clin Oncol; 2004 Jun; 34(6):316-22. PubMed ID: 15333683 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]